Varus is proud to announce its collaboration with Genekor Medical S.A., a leader in molecular diagnostics, to deliver next-generation solutions in precision medicine. This strategic alliance is focused on improving cancer patient care by introducing an innovative approach to the diagnosis and treatment of malignant diseases in our country.
With the introduction of cutting-edge molecular technologies, the boundaries of current scientific and clinical practices are being elevated to a higher level. This partnership enables the application of molecular diagnostics to develop transformative solutions that contribute to a personalized approach to oncology treatment.
As part of this collaboration, Varus and Genekor Medical S.A. will combine their expertise to:
- Improve early diagnosis of malignant diseases
- Provide tools for individualized treatment;
- Deliver effective and efficient healthcare solutions
The collaboration will focus on the field of oncology and will include:
- Molecular response to therapy;
- Identification of hereditary syndromes;
- Early detection of malignant diseases;
- Pharmacogenomics – genomic analysis of response to pharmacotherapy.
- Scientific support and counseling for genetic predispositions.
This partnership represents a significant step forward in improving cancer care and treatment, providing access to the most advanced molecular analyses that will greatly contribute to better health outcomes for patients. Varus and Genekor Medical S.A. remain committed to introducing innovative, cost-effective healthcare solutions to improve patients’ quality of life and ensure more efficient treatment.
